Publication October 29, 2026

New Publication: Thymosin Alpha-1 Meta-Analysis in Colorectal Cancer Therapy

A new publication involving thymosin alpha-1 was announced on October 29, 2026. The paper, titled "Efficacy and safety of thymosin combined with anticancer therapy for colorectal cancer: a systematic review and meta-analysis of controlled studies," appeared in Frontiers in Oncology. The work is described as a systematic review and meta-analysis of controlled studies examining thymosin used alongside anticancer therapy in colorectal cancer. This entry reflects only the publication record as listed, including its title, journal, and date. No specific findings, outcomes, or conclusions from the study are included here. Thymosin alpha-1 carries an unapproved research status, and this publication does not change that status. Readers should consult the original article for full methodology and results. For general background on thymosin alpha-1, including its research classification and other published findings, readers can refer to the compound overview.

See the full thymosin alpha-1 overview

Source: https://pubmed.ncbi.nlm.nih.gov/43022192/